|
Commentary on "clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
|
Jan 2015
|
Nat Commun.
|
myelodysplastic syndromes (MDS)
|
|
Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis
|
Nov 2017
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Combination strategies in myelodysplastic syndromes.
|
Jan 2012
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
|
Aug 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
|
May 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Clustering of comorbidities is related to age and sex and impacts clinical outcome in myelodysplastic syndromes
|
Mar 2014
|
J Geriatr Oncol
|
myelodysplastic syndromes (MDS)
|
|
Clonal selection in therapy related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment
|
Jan 2020
|
European Journal of Haematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
|
Apr 2015
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Clonal hematopoiesis in acquired aplastic anemia
|
Apr 2016
|
Blood
|
aplastic anemia
|
